Quantcast

Latest Antimalarial drug Stories

2010-01-11 16:34:36

Researchers are a step closer to developing new antimalarial drugs after discovering the normal function of a set of proteins related to the malaria parasite protein, which causes resistance to the front-line drug chloroquine. The findings also provide a novel tool for studying the malarial chloroquine-resistance factor. The study examined transporter proteins which are known to move compounds around the cell. The genes for these proteins are present in plants as well as the malaria parasite...

2009-12-22 14:00:28

Johns Hopkins Scientists Find a Source of Nonallergic Itch Scratching below the surface of a troublesome sensation that's equal parts tingle-tickle-prickle, sensory scientists from Johns Hopkins have discovered in mice a molecular basis for nonallergic itch. Using the itch-inducing compound chloroquine, an antimalarial drug, the team identified that a family of proteins called Mrgprs, found only in a rare subset of nerve cells, functions as itch receptors. A report on the research appears...

2009-12-14 05:00:00

LONDON, Dec. 14 /PRNewswire-FirstCall/ -- A new solution developed by IBM (NYSE: IBM), Novartis and Vodafone with the Roll Back Malaria Partnership, is helping to save lives using everyday technology to improve the availability of anti-malarial drugs in remote areas of Tanzania. (Photo: http://www.newscom.com/cgi-bin/prnh/20091214/NY25146-a ) (Photo: http://www.newscom.com/cgi-bin/prnh/20091214/NY25146-b ) (Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO ) Called "SMS for...

2009-11-19 13:04:00

WASHINGTON, Nov. 19 /PRNewswire/ -- Evidence of resistance to the antimalarial drug artemisinin and its derivatives threatens efforts to control malaria in Southeast Asia, and experts fear artemisinin resistance may spread from the Thailand-Cambodia border to affect other malaria endemic countries. Evidence to such effect was presented today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH). The prospect of spreading artemisinin resistance is...

2009-11-18 14:00:00

WASHINGTON, Nov. 18 /PRNewswire-USNewswire/ -- While efforts to control and eliminate malaria have made great strides during the past five years, the looming specter of drug resistance heightens the importance of continued research and development for new tools to assure continued success, according to malaria scientists and public health experts appearing today on Capitol Hill. The briefing, sponsored by the American Society for Tropical Medicine and Hygiene (ASTMH), PATH, and Malaria No...

2009-11-12 12:43:58

Top scientists reveal the latest innovations in genetically modified mosquitoes, new diagnostic tests and mapping mosquito migrations In a novel approach at disseminating scientific research, the Johns Hopkins Malaria Research Institute (JHMRI) will hold a web summit to release the latest breakthroughs in malaria research, including new approaches to boosting mosquito immunity to malaria, mapping mosquito migrations, and the promise of a rapid sputum test that could revolutionize the way...

2009-11-02 07:30:00

Unprecedented data from ACTwatch unveils low accessibility of ACTs ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk. Announcing the results at the 5th Multilateral Initiative on Malaria (MIM)...

2009-10-29 09:27:15

Scientists at LSTM have developed a tool to support the development of appropriate age-based dosing regimens for malaria drugs. Weight-based dosing is challenging in many malaria endemic countries because access to formal health services is limited, functioning scales may be scarce and many treatments are given at home using antimalarials bought from shops and street vendors.  In these settings, drug doses are calculated using a patient's age to estimate their body weight. There are no...

2009-09-16 18:01:00

BARCELONA, Spain, September 17 /PRNewswire/ -- A third (30%) of malaria cases can be avoided in African infants using a safe, affordable and simple tool called Intermittent Preventive Treatment of malaria in Infants (IPTi) with the medicine sulphadoxine-pyrimethamine (SP), which can be delivered alongside existing childhood vaccination programmes.(i) Results of a meta-analysis examining six clinical trials in Africa for the malaria intervention which the World Health Organization already...

2009-09-10 13:35:23

A new study in Bangladesh suggests tigecycline -- the first member of a new class of antibiotics -- might be effective against multi-drug-resistant malaria. Researchers said tigecycline shows significant anti-malarial activity on its own and can be administered in combination with traditional anti-malarial drugs. The increasing drug resistance of Plasmodium falciparum, one of the parasites that cause malaria, has resulted in the search for new anti-malarial therapies. The scientists said...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related